Company intelligence / Profile preview

Novadaq Technologies

Mississauga, Ontario, Canada

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Novadaq’s SPY fluorescence imaging systems—including SPY Elite and PINPOINT—enabled real-time visualization of blood flow and tissue perfusion during complex surgeries, with demonstrated reduction in postoperative complications. Clinical programs included applications in lymphatic mapping in breast cancer and perfusion imaging in reconstructive, cardiovascular, gastrointestinal, and microsurgical fields; products were FDA-approved before company acquisition[2][4].

Therapeutic areas: CardiovascularOncology
Modalities: DeviceImaging agent (Indocyanine green)Software
Industry: Medical Imaging

Partnerships

LifeCellKinetic Concepts (KCI)Intuitive SurgicalMaquet Cardiovascular

Beyond the preview

Go deeper on Novadaq Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novadaq Technologies.

Explore the full profile